Shrayanee Das

Shrayanee Das

Auto-generated profile, based on publicly available information

Shrayanee Das

Amity Institute of Biotechnology, Amity University Haryana, Manesar, Gurugram 122413, India

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Interdisciplinary Perspectives on Infectious Diseases
Verified
Journal Article
Open access
PDF file
JTJyoti Tanwar
Jyoti Tanwar
SDShrayanee Das
Shrayanee Das
ZFZEESHAN FATIMA
ZEESHAN FATIMA
SHSAIF HAMEED
SAIF HAMEED
The resistance among various microbial species (infectious agents) to different antimicrobial drugs has emerged as a cause of public health threat all over the world at a terrifying rate. Due to the pacing advent of new resistance mechanisms and decrease in efficiency of treating common infectious diseases, it results in failure of microbial response to standard treatment, leading to prolonged illness, higher expenditures for health care, and an immense risk of death. Almost all the capable infecting agents (e.g., bacteria, fungi, virus, and parasite) have employed high levels of multidrug resistance (MDR) with enhanced morbidity and mortality; thus, they are referred to as “super bugs.” Although the development of MDR is a natural phenomenon, the inappropriate use of antimicrobial drugs, inadequate sanitary conditions, inappropriate food-handling, and poor infection prevention and control practices contribute to emergence of and encourage the further spread of MDR. Considering the significance of MDR, this paper, emphasizes the problems associated with MDR and the need to understand its significance and mechanisms to combat microbial infections.

31 January 2018 in Journal of Pathogens
Verified
Journal Article
Open access
PDF file
RPRahul Pal
Rahul Pal
MAMoiz A. Ansari
Moiz A. Ansari
VSVenkata Saibabu
Venkata Saibabu
SDShrayanee Das
Shrayanee Das
ZFZEESHAN FATIMA
ZEESHAN FATIMA
SHSAIF HAMEED
SAIF HAMEED
Significance of methylene blue (MB) in photodynamic therapy against microbes is well established. Previously, we have reported the antifungal potential of MB againstCandida albicans. The present study attempts to identify additional antimicrobial effect of MB against another prevalent human pathogen,Mycobacterium tuberculosis(MTB). We explored that MB is efficiently inhibiting the growth ofMycobacteriumat 15.62 μg/ml albeit in bacteriostatic manner similar to its fungistatic nature. We uncovered additional cell surface phenotypes (colony morphology and cell sedimentation rate) which were impaired only inMycobacterium. Mechanistic insights revealed that MB causes energy dependent membrane perturbation in bothC. albicansandMycobacterium. We also confirmed that MB leads to enhanced reactive oxygen species generation in both organisms that could be reversed upon antioxidant supplementation; however, DNA damage could only be observed inMycobacterium. We provided evidence that although biofilm formation was disrupted in both organisms, cell adherence to human epithelial cells was inhibited only inMycobacterium. Lastly, RT-PCR results showed good correlation with the biochemical assay. Together, apart from the well-established role of MB in photodynamic therapy, this study provides insights into the distinct antimicrobial mode of actions in two significant human pathogens,CandidaandMycobacterium,which can be extrapolated to improve our understanding of finding novel therapeutic options.